National Heart, Lung, and Blood Institute (NHLBI): Diabetes Mellitus trials
The registry lists 20 Diabetes Mellitus studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 0 are open to participants now and 1 have results posted.
Phase 2 1Phase 3 1No phase 18(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Action to Control Cardiovascular Risk in Diabetes (ACCORD)CompletedNCT00000620Phase 3Results posted
- Links Between Inflammation and Cardiometabolic DiseasesCompletedNCT01934660
- Relation of White Blood Cell Function to DiabetesCompletedNCT00570154
- Rosiglitazone to Reverse Metabolic Defects in DiabetesCompletedNCT00094796Phase 2
- Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2DCompletedNCT00041405
- Epidemiology of Cardiovascular Disease in DiabetesCompletedNCT00037297
- VA HDL Intervention Trial (VA-HIT) Ancillary Study Data AnalysisCompletedNCT00035711
- Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEADCompletedNCT00031239
- Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEADCompletedNCT00031213
- MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEADCompletedNCT00031200
- Prenatal Nutrition and Adult DiseaseCompletedNCT00024583
- Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic ControlCompletedNCT00021944
- Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNTCompletedNCT00021918
- Multi-Ethnic Study of Atherosclerosis (MESA)Active, not recruitingNCT00005487
- The Jackson Heart Study of Cardiovascular Disease Among African AmericansActive, not recruitingNCT00005485
- Genetics of Atherosclerosis in Mexican AmericansCompletedNCT00005462
- Prospective Study of Diabetes-related Vascular Disease in Oklahoma IndiansCompletedNCT00005193
- Cardiovascular Health Study (CHS)Active, not recruitingNCT00005133
- Coronary Artery Risk Development in Young AdultsActive, not recruitingNCT00005130
- Deferoxamine for the Treatment of HemochromatosisCompletedNCT00001203